Literature DB >> 23246679

Signaling cascades initiated by TSLP-mediated signals in different cell types.

Xiaozhou Yu1, Hui Li, Xiubao Ren.   

Abstract

Thymic stromal lymphopoietin (TSLP) has been well characterized as a consequence of its ability to modulate allergic and neoplastic diseases. However, downstream signaling mediated by TSLP varies significantly between the cell type and species examined. Since this observation is often overlooked and in some cases ignored, this review aims to consolidate the molecular pathways activated by TSLP receptors expressed by various human and mouse cell types. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246679     DOI: 10.1016/j.cellimm.2012.10.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

Review 1.  TSLP Inhibitors for Asthma: Current Status and Future Prospects.

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Blockage of thymic stromal lymphopoietin signaling improves acute lung injury in mice by regulating pulmonary dendritic cells.

Authors:  Guoquan Pan; Yafeng Liang; Lu Lu; Xu Chen; Min Wang; Linxia Wang; Chunxue Yan; Weixi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Potential Targets to Mitigate Trauma- or Sepsis-Induced Immune Suppression.

Authors:  Christian B Bergmann; Nadine Beckmann; Christen E Salyer; Marc Hanschen; Peter A Crisologo; Charles C Caldwell
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.